Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-004458
Filing Date
2025-07-03
Accepted
2025-07-03 13:23:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2843
  Complete submission text file 0001959173-25-004458.txt   4459
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
Moukheibir Catherine (Reporting) CIK: 0001772130 (see all company filings)

Type: 144

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Subject) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39630 | Film No.: 251104771
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)